{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:53:34Z","timestamp":1793656414975,"version":"4.5.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014472","name":"Scientific Research Foundation of Hunan Provincial Education Department","doi-asserted-by":"publisher","award":["23B0402"],"award-info":[{"award-number":["23B0402"]}],"id":[{"id":"10.13039\/100014472","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014472","name":"Scientific Research Foundation of Hunan Provincial Education Department","doi-asserted-by":"publisher","award":["23B0441"],"award-info":[{"award-number":["23B0441"]}],"id":[{"id":"10.13039\/100014472","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014472","name":"Scientific Research Foundation of Hunan Provincial Education Department","doi-asserted-by":"publisher","award":["22C0226"],"award-info":[{"award-number":["22C0226"]}],"id":[{"id":"10.13039\/100014472","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ40571"],"award-info":[{"award-number":["2023JJ40571"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2022JJ40356"],"award-info":[{"award-number":["2022JJ40356"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ30527"],"award-info":[{"award-number":["2023JJ30527"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ40561"],"award-info":[{"award-number":["2023JJ40561"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22107034"],"award-info":[{"award-number":["22107034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejmech.2024.116807","type":"journal-article","created":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T01:20:13Z","timestamp":1725153613000},"page":"116807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Identification of a novel 10-hydroxyevodiamine prodrug as a potent topoisomerase inhibitor with improved aqueous solubility for treatment of hepatocellular carcinoma"],"prefix":"10.1016","volume":"279","author":[{"given":"Xiuzhen","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxuan","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zecheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4134-1779","authenticated-orcid":false,"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3670-124X","authenticated-orcid":false,"given":"Linsheng","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116807_bib1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.bi.65.070196.003223","article-title":"DNA topoisomerases","volume":"65","author":"Wang","year":"1996","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2024.116807_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/S003358350800468X","article-title":"DNA topoisomerases: harnessing and constraining energy to govern chromosome topology","volume":"41","author":"Schoeffler","year":"2008","journal-title":"Q. Rev. Biophys."},{"key":"10.1016\/j.ejmech.2024.116807_bib3","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1021\/jm010329a","article-title":"Novel angular benzophenazines: dual topoisomerase I and topoisomerase II inhibitors as potential anticancer agents","volume":"45","author":"Vicker","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116807_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104398","article-title":"Irinotecan: 25 years of cancer treatment","volume":"148","author":"Bailly","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2024.116807_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1634\/theoncologist.9-1-33","article-title":"Topotecan dosing guidelines in ovarian cancer: reduction and management of hematologic toxicity","volume":"9","author":"Armstrong","year":"2004","journal-title":"Oncol."},{"key":"10.1016\/j.ejmech.2024.116807_bib6","doi-asserted-by":"crossref","first-page":"8947","DOI":"10.1021\/acs.jmedchem.7b01202","article-title":"Discovery of novel topoisomerase II inhibitors by medicinal chemistry approaches","volume":"61","author":"Hu","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116807_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032532","article-title":"A mini review of novel topoisomerase II inhibitors as future anticancer agents","volume":"24","author":"Okoro","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116807_bib8","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/med.21417","article-title":"Topoisomerases: resistance versus sensitivity, how far we can go?","volume":"37","author":"Bansal","year":"2017","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2024.116807_bib9","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/ijc.2910500516","article-title":"Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude mice","volume":"50","author":"Kim","year":"1992","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejmech.2024.116807_bib10","doi-asserted-by":"crossref","first-page":"12873","DOI":"10.1021\/acs.jmedchem.0c00774","article-title":"Novel, potent, and druglike tetrahydroquinazoline inhibitor that is highly selective for human topoisomerase II alpha over beta","volume":"63","author":"Ortega","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116807_bib11","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.2174\/092986710793361252","article-title":"Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs","volume":"17","author":"Salerno","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116807_bib12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2174\/1568026033452555","article-title":"Dual topoisomerase I\/II inhibitors in cancer therapy","volume":"3","author":"Denny","year":"2003","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116807_bib13","doi-asserted-by":"crossref","first-page":"8040","DOI":"10.1021\/acs.jmedchem.2c00615","article-title":"Optimization of the natural product calothrixin A to discover novel dual topoisomerase I and II inhibitors with improved anticancer activity","volume":"65","author":"Yang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116807_bib14","doi-asserted-by":"crossref","first-page":"9828","DOI":"10.1021\/acs.jmedchem.0c00983","article-title":"Discovery of evodiamine derivatives as highly selective PDE5 inhibitors targeting a unique allosteric pocket","volume":"63","author":"Zhang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116807_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115031","article-title":"Natural product evodiamine-inspired medicinal chemistry: anticancer activity, structural optimization and structure-activity relationship","volume":"247","author":"Wang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116807_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114530","article-title":"Design, synthesis and bioactivity evaluation of favorable evodiamine derivative scaffold for developing cancer therapy","volume":"239","author":"Liang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116807_bib17","doi-asserted-by":"crossref","first-page":"6678","DOI":"10.1021\/acs.jmedchem.5b00910","article-title":"Scaffold diversity inspired by the natural product evodiamine: discovery of highly potent and multitargeting antitumor agents","volume":"58","author":"Wang","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116807_bib18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0378-4347(95)00090-6","article-title":"High-performance liquid chromatographic determination of evodiamine in rat plasma: application to pharmacokinetic studies","volume":"668","author":"Jeng","year":"1995","journal-title":"J. Chromatogr. B Biomed. Appl."},{"key":"10.1016\/j.ejmech.2024.116807_bib19","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ptr.4766","article-title":"Investigation of the in vitro metabolism of evodiamine: characterization of metabolites and involved cytochrome p450 isoforms","volume":"27","author":"Sun","year":"2013","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejmech.2024.116807_bib20","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.enzmictec.2005.10.029","article-title":"Microbial metabolism of evodiamine by Penicillium janthinellum and its application for metabolite identification in rat urine","volume":"39","author":"Li","year":"2006","journal-title":"Enzym. Microb. Technol."},{"key":"10.1016\/j.ejmech.2024.116807_bib21","doi-asserted-by":"crossref","first-page":"7593","DOI":"10.1021\/jm300605m","article-title":"New tricks for an old natural product: discovery of highly potent evodiamine derivatives as novel antitumor agents by systemic structure-activity relationship analysis and biological evaluations","volume":"55","author":"Dong","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116807_bib22","doi-asserted-by":"crossref","first-page":"17346","DOI":"10.1021\/acs.jmedchem.1c01411","article-title":"Discovery of novel polycyclic heterocyclic derivatives from evodiamine for the potential treatment of triple-negative breast cancer","volume":"64","author":"Xu","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116807_bib23","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1021\/acs.jmedchem.9b01626","article-title":"Scaffold hopping of natural product evodiamine: discovery of a novel antitumor scaffold with excellent potency against colon cancer","volume":"63","author":"Wang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116807_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116595","article-title":"Design, synthesis and bioactivity evaluation of novel N-phenyl-substituted evodiamine derivatives as potent anti-tumor agents","volume":"55","author":"Hao","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116807_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113960","article-title":"Design, synthesis and bioactivity evaluation of novel evodiamine derivatives with excellent potency against gastric cancer","volume":"228","author":"Liang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116807_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105154","article-title":"Design, synthesis and bioactivity study of evodiamine derivatives as multifunctional agents for the treatment of hepatocellular carcinoma","volume":"114","author":"Fan","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116807_bib27","doi-asserted-by":"crossref","first-page":"7975","DOI":"10.1021\/acs.jmedchem.2c00520","article-title":"Design, synthesis, and biological evaluation of novel evodiamine derivatives as potential antihepatocellular carcinoma agents","volume":"65","author":"Lei","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116807_bib28","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1039\/C9CC00434C","article-title":"A concise synthesis and biological study of evodiamine and its analogues","volume":"55","author":"Deng","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2024.116807_bib29","doi-asserted-by":"crossref","first-page":"11220","DOI":"10.1039\/C6OB02120D","article-title":"Synthetic analogs of stryphnusin isolated from the marine sponge Stryphnus fortis inhibit acetylcholinesterase with no effect on muscle function or neuromuscular transmission","volume":"14","author":"Moodie","year":"2016","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2024.116807_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ajco.13443","article-title":"A clinical trial with valproic acid and hydralazine in combination with gemcitabine and cisplatin followed by doxorubicin and dacarbazine for advanced hepatocellular carcinoma","volume":"18","author":"Liu","year":"2022","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2024.116807_bib31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13046-022-02482-3","article-title":"Hsa_circ_0000098 is a novel therapeutic target that promotes hepatocellular carcinoma development and resistance to doxorubicin","volume":"41","author":"Li","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2024.116807_bib32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","article-title":"The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects","volume":"5","author":"Tang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2024.116807_bib33","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2024.116807_bib34","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ijbiomac.2018.12.268","article-title":"Apoptosis of human gastric carcinoma MGC-803 cells induced by a novel Astragalus membranaceus polysaccharide via intrinsic mitochondrial pathways","volume":"126","author":"Yu","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2024.116807_bib35","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.redox.2017.01.013","article-title":"Mitochondrial dynamics in type 2 diabetes: pathophysiological implications","volume":"11","author":"Rovira-Llopis","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2024.116807_bib36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ccr.2006.08.015","article-title":"Reactive oxygen species in cancer cells: live by the sword, die by the sword","volume":"10","author":"Schumacker","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2024.116807_bib37","doi-asserted-by":"crossref","first-page":"7521","DOI":"10.1021\/jm100387d","article-title":"Selection of evodiamine as a novel topoisomerase I inhibitor by structure-based virtual screening and hit optimization of evodiamine derivatives as antitumor agents","volume":"53","author":"Dong","year":"2010","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424006883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424006883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T15:38:45Z","timestamp":1731253125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424006883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":37,"alternative-id":["S0223523424006883"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116807","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of a novel 10-hydroxyevodiamine prodrug as a potent topoisomerase inhibitor with improved aqueous solubility for treatment of hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116807","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116807"}}